(Q63010862)
Statements
A Phase IV, Prospective, Open-label, Multicentre, Single Arm, 3-month Proof of Concept Study to Assess the Effect of IKERVIS® Eye Drops Administered Once Daily on the Quality of Vision in Dry Eye Disease (DED) Patients With Severe Keratitis (English)
0 references
28 March 2017
0 references
July 2018
0 references
33
0 references
18 year
0 references
99 year
0 references